---
layout: default
title: Alpha -Tocopherol Acetate Dl- Ascorbic Acid Calciu
parent: 僅模型預測 (L5)
nav_order: 225
evidence_level: L5
indication_count: 0
---

# Alpha -Tocopherol Acetate Dl- Ascorbic Acid Calciu
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# DL-α-Tocopherol / Ascorbic Acid / Cholecalciferol / DHA Complex: Nutritional Supplement — No Repurposing Predictions Available

---

## One-Sentence Summary

This evidence pack describes an 8-component nutritional supplement combination — comprising Vitamin E, Vitamin C, Calcium, Vitamin D3, Doconexent (DHA), Ferrous Fumarate, Folic Acid, and Pyridoxine — consistent with a prenatal multivitamin formulation.
The TxGNN model returned **no repurposing predictions** for this multi-component query, and the combination is currently **not registered in Taiwan**.
With no original indication on record, no predicted indications, and critical data gaps throughout, this candidate cannot advance to repurposing evaluation at this stage.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | Not on record |
| Predicted New Indication | No predictions generated |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 — model prediction unavailable |
| Taiwan Market Status | ✗ Not marketed (0 registrations) |
| Number of Registrations | 0 |
| Recommended Decision | **Hold** |

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The TxGNN pipeline could not generate any repurposing predictions for this multi-component query. Without a single active ingredient resolved to a DrugBank ID, the knowledge graph has no node to traverse, making all downstream scoring impossible.

**To proceed, the following is needed:**

- **Decompose the query into individual active ingredients.** Each component (e.g., Doconexent / DHA as DB02088, Cholecalciferol as DB00169, Folic Acid as DB00158) should be submitted as a separate TxGNN query. Multi-component strings are not resolvable by the current mapping layer.
- **Confirm clinical intent.** Identify whether the target indication is pregnancy support, a specific deficiency condition, or another therapeutic area — this determines which component(s) to prioritise.
- **Resolve the DrugBank ID.** The DrugBank query returned 1 result (`result_count: 1`) but no structured data was captured. Retrieve the full DrugBank record to obtain MOA, categories, and approved indications.
- **Obtain regulatory package insert.** No Taiwan registration exists; sourcing a comparable US FDA or EMA-approved product label (e.g., prenatal vitamin NDA) would fill the safety and indication data gaps.
- **Re-run the Evidence Pack pipeline** after the above steps to generate a complete candidate report.
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

